2438 Results for "

decrease

" in MedChemExpress (MCE) Product Catalog:
Products (2438)

2438 Results for "decrease" in MCE Product Catalog:

Referencia número: HY-110020
No. CAS: 851320-29-1
Target:  

Cannabinoid Receptor

Áreas de investigación:  

Metabolic Disease

rel-O-2050 (Compound O-2050) is a neutral cannabinoid CB1 receptor antagonist. rel-O-2050 also decreases food intake in mice .
loading...
    loading...
Referencia número: HY-111308
No. CAS: 847554-50-1
Áreas de investigación:  

Neurological Disease

RTI-118 is a novel small-molecule neuropeptide S receptor (NPSR) antagonist. RTI-118 can relieve agent addiction including selectively decrease self-administration .
loading...
    loading...
Referencia número: HY-117805
No. CAS: 177847-28-8
Target:  

Angiotensin Receptor

Áreas de investigación:  

Cardiovascular Disease

UR-7247 is a potent and orally active angiotensin II AT1 receptor antagonist. UR-7247 decreases arterial pressure and increases renal blood flow .
loading...
    loading...
Referencia número: HY-119926
No. CAS: 15358-48-2
Synonyms: Hydroxylupanine
Target:  

Integrin

Áreas de investigación:  

Cardiovascular Disease Neurological Disease

13-Hydroxylupanine (Hydroxylupanine) is the typical alkaloid profile of sweet lupins.13-Hydroxylupanine blocks ganglionic transmission, decreases cardiac contractility and contracts uterine smooth muscle .
loading...
    loading...
Referencia número: HY-119926A
No. CAS: 6809-89-8
Synonyms: Hydroxylupanine hydrochloride
13-Hydroxylupanine Hydroxylupanine is the typical alkaloid profile of sweet lupins. 13-Hydroxylupanine Hydroxylupanine blocks ganglionic transmission, decreases cardiac contractility and contracts uterine smooth muscle .
loading...
    loading...
Referencia número: HY-122101
No. CAS: 17392-79-9
Target:  

JAK Apoptosis

Áreas de investigación:  

Cancer

NSC114792 is a selective JAK3 inhibitor. NSC114792 induces apoptosis. NSC114792 decreases the protein expression of p-JAK3 and p-STAT5 .
loading...
    loading...
Referencia número: HY-126852
No. CAS: 163217-70-7
Synonyms: P-Hydroxyatorvastatin lactone; 4-ATL
Target:  

Drug Metabolite

Áreas de investigación:  

Metabolic Disease Inflammation/Immunology

4-Hydroxy Atorvastatin lactone is a metabolite of Atorvastatin (HY-B0589). Atorvastatin is an orally active HMG-CoA reductase inhibitor, has the ability to effectively decrease blood lipids .
loading...
    loading...
Referencia número: HY-136676
No. CAS: 122088-76-0
Target:  

Renin

Áreas de investigación:  

Cancer

Cgp 38560 methanesulfonate is a well-tolerated renin inhibitor. Cgp 38560 methanesulfonate caused a dose-dependent decrease in angiotensin II and plasma renin activity, and a dose-dependent increase in active renin.
loading...
    loading...
Referencia número: HY-147327
No. CAS: 26367-45-3
Target:  

Drug Metabolite

Áreas de investigación:  

Cancer

N-Formylsarcolysine has antitumor activity, and inhibits leukemia by increasing the Hb and erythrocyte levels and decreasing the number of leukocytes. N-Formylsarcolysine also involves in glioblastoma and other diseases research .
loading...
    loading...
Referencia número: HY-158329
No. CAS: 561022-65-9
Pureza:  98.40%
Synonyms: N-Alloc doxorubicin
Áreas de investigación:  

Cancer

Alloc-DOX (N-Alloc doxorubicin) is a Doxorubicin (HY-15142A) prodrug. The combination of a catalyst (such as nano-palladium) and alloc-DOX leads to a decrease in cell viability and tumour growth .
loading...
    loading...
Referencia número: HY-163279
No. CAS: 885902-66-9
Target:  

Glycosidase

Áreas de investigación:  

Others

Fluopipamine is an antagonist for Cellulose Synthase 1 (CESA1) with an IC50 of 0.78 μM. Fluopipamine leads a decrease in glucose uptake into cellulose and hyperaccumulation of CESAs at the PM in etiolated Arabidopsis seedlings .
loading...
    loading...
Referencia número: HY-179114
No. CAS: 1211788-57-6
Áreas de investigación:  

Others

VU0519975 is a raft destabilizing compound. VU0519975 reduces PMP22 raft partitioning and destabilizes ordered domains. VU0519975 significantly decreases the fraction of phase separated GPMVs .
loading...
    loading...
Referencia número: HY-180958
No. CAS: 3104316-26-6
Target:  

PROTACs

Áreas de investigación:  

Others

Chlorohexane-PEG-clozapine is a HaloTag PROTAC degrader based on Clozapine (HY-14539). Chlorohexane-PEG-clozapine leads to a significant decrease in the luminescence intensity and protein level of Halo-Eluc .
loading...
    loading...
Referencia número: HY-B0606A
No. CAS: 59985-21-6
Synonyms: INS365 free base
Diquafosol (INS365 free base) is a potent P2Y2 agonist. Diquafosol nhibits apoptosis and decreases ROS generation. Diquafosol has the potential for the research of dry eye .
loading...
    loading...
Referencia número: HY-N7646
No. CAS: 143601-09-6
Curculigoside B, a phenolic glycoside isolated from Curculigo orchioides, enhances the osteoblast proliferation, decreases the area of bone resorption pit, osteoclastic formation and TRAP activity. Antiosteoporotic and antioxidative activities .
loading...
    loading...
Referencia número: HY-P3637
No. CAS: 2640019-27-6
Target:  

Inhibitory Antibodies

Áreas de investigación:  

Inflammation/Immunology

AVSEHQLLHDKGKSIQDLRRRFFLHHLI-{Aib}-EIHTAYRFGG promotes bone-ossification. AVSEHQLLHDKGKSIQDLRRRFFLHHLI-{Aib}-EIHTAYRFGG can be used in the research of diseases or disorders related to osteogenic defects or bone mineral density (BMD) decreasing, such as osteoporosis .
loading...
    loading...
Referencia número: HY-P99627
No. CAS: 1708936-80-4
Synonyms: NV-02; PG110; ABT-110

Target:  

Trk Receptor

Áreas de investigación:  

Inflammation/Immunology

Frunevetmab (NV-02) is a felinized anti-nerve growth factor (NGF) monoclonal antibody with a Kd of 20 pM. Frunevetmab can effectively decrease osteoarthritis (OA) pain in cats .
loading...
    loading...
Referencia número: HY-116953
No. CAS: 98049-69-5
Synonyms: LXB4
Target:  

Endogenous Metabolite

Áreas de investigación:  

Inflammation/Immunology

Lipoxin B4 (LXB4) is a structurally distinct product of arachidonic acid metabolism. Lipoxin B4 reduces leukocyte infiltration and mucus secretion in the nasal mucosa and decreases mast cell and eosinophil degranulation in the upper airway. Lipoxin B4 decreases airway inflammation, mucus metaplasia and hyper- responsiveness in the lower airway. Lipoxin B4 shows mucosal protective actions and has the potential for the research of allergic inflammation in the upper and lower airways .
The product specifications provided below refer solely to the active content of Lipoxin B4.
loading...
    loading...
Referencia número: HY-120152
No. CAS: 1449765-82-5
SLP7111228 is a selective sphingosine kinase 1 (SphK1) inhibitor and anti-inflammatory agent. SLP7111228 selectively inhibits SphK1 and reduces the production of sphingosine-1-phosphate. SLP7111228 decreases lipopolysaccharide-induced TNFα and IL-1β levels. SLP7111228 alleviates obliterative pulmonary arteriopathy, increases cardiac index and decreases total pulmonary vascular resistance index. SLP7111228 can be used in research related to neuroinflammatory diseases and pulmonary hypertension .
loading...
    loading...
Referencia número: HY-120152A
No. CAS: 1449768-48-2
Pureza:  98.0%
SLP7111228 hydrochloride is a selective sphingosine kinase 1 (SphK1) inhibitor and anti-inflammatory agent. SLP7111228 hydrochloride selectively inhibits SphK1 and reduces the production of sphingosine-1-phosphate. SLP7111228 hydrochloride decreases lipopolysaccharide-induced TNFα and IL-1β levels. SLP7111228 hydrochloride alleviates obliterative pulmonary arteriopathy, increases cardiac index and decreases total pulmonary vascular resistance index. SLP7111228 hydrochloride can be used in research related to neuroinflammatory diseases and pulmonary hypertension .
loading...
    loading...